Drugs Approved Under Deadline More Likely to Run Into Tro... (and maintaining FDA drug approval he sa...)

Drugs Approved Under Deadline More Likely to Run Into Trouble Later

Date:3/26/2008

and maintaining FDA drug approval," he said. "Nobody wants to go back to the years where it was taking three to four years to get drugs through the FDA. Right now, 90 percent of these drugs have to be decided on in a certain time. What if we pushed that back to 60, 70, 80 percent and doubled the number of people reviewing drugs?"

Nissen said: "I also think we need to distinguish between routine approval and approvals of drugs that are really breakthrough drugs. I would argue compelling reason to move drugs that have major new benefits through the process more quickly... But 'me-too' drugs -- that's another drug in the same class where there are already drugs available -- that may not fit the bill. What you really want to do is accelerate the novel drugs. PDUFA doesn't distinguish, but I think it's a problem."

The FDA said it was performing its own analysis.

Another study, this one published in the March 26 issue of the Journal of the American Medical Association, looked at differences in the approval process for two lipid-altering drugs.

The first, ezetimibe, was approved in October 2002 on the basis of its ability to reduce LDL ("bad") cholesterol levels but without evidence of its effects on atherosclerosis or clinical events. A large trial to evaluate the drug more closely for major cardiovascular events began in January 2006 but is not expected to end until January 2011. Nevertheless, the drug was approved and marketed aggressively (sales reached $5 billion in 2007).

On the other hand, torcetrapib, a drug developed to raise HDL ("good") cholesterol levels never made it to market because a large, well-designed trial found an increased incidence of major cardiovascular events and death. The trial was halted early and the drug was never approved.

"Of the two approaches, torcetrapib was clearly the more successful," wrote the study's author, Dr. Bruce Psaty of the University of Washington, in Seattl
'/>"/>

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. New review suggests caution on drugs to raise good cholesterol
2. Can cancer drugs combine forces?
3. Study provides hope that some transplant patients could live free of antirejection drugs
4. Study provides hope that some transplant patients could live free of anti-rejection drugs
5. RA Drugs Linked to Slight Skin Cancer Risk
6. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
7. Rock N Roll: Sex, Drugs and an Early Exit
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
10. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
11. 2 drugs equally effective for heart patients undergoing angioplasty, Mayo study finds

Post Your Comments:

Related Image:

Drugs Approved Under Deadline More Likely to Run Into Trouble Later

(Date:12/14/2009)... Young Adults, Attitudes and Behavior Regarding Pregnancy, Contraception, and ... -- Nearly all unmarried young adults ages 18-29 believe ... men and 86% of women) and say that it ... now (86% of men and 88% of women), according ... Prevent Teen and Unplanned Pregnancy. Even so: ,, ...

(Date:12/14/2009)... HOLLYWOOD, Fla., Dec. 14 Abbott ... a definitive agreement to acquire STARLIMS Technologies ... provider of laboratory information management systems, for ... The acquisition strengthens Abbott,s competitive position in ... applications to help laboratories efficiently store, retrieve ...

(Date:12/14/2009)... The National Organization for Rare Disorders (NORD) today called ... and annual health insurance caps. In a full-page ... widely on Capitol Hill, NORD said the current Senate ... to continue for most Americans, contrary to what many ... and welcomes the promises made by President Obama and ...

(Date:12/14/2009)... 13 years under government controlled health care, before moving to the ... engagements and in his new book, Health Reform: The End of ... a system and its threat to real health care! , ... ... a diagnostic radiologist from Minnesota, warns Americans not to sell out ...

(Date:12/14/2009)... Legislation Critical to Stemming Tide of Tens of ... ,, WASHINGTON, Dec. 14 Legislation approved ... exchange will be crucial in helping to reduce ... occurring each year in the United States, the ... today. The provision was included in the ...

Breaking Medicine News(10 mins):Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 2 Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 3 Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2 Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3 Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4 Health News:NORD Calls for Immediate End to Lifetime Insurance Caps 2 Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2 Health News:NVHR Applauds Congressional Action to End Federal Ban on Funding Syringe Exchange 2

[1] Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference [0] Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems [0] NORD Calls for Immediate End to Lifetime Insurance Caps [2] Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America [0] NVHR Applauds Congressional Action to End Federal Ban on Funding Syringe Exchange

... say , moms-to-be who are carrying girls are more ... than pregnant asthmatic women carrying boys. Doctors speculate female ... inflammation of the mother’s airways that somehow worsens the ... of asthmatic women who were pregnant with boys were ...

... an effective combination treatment for patients with advanced prostate ... cancer death in men and// according to the American ... of prostate cancer diagnosed this year. ,The ... steroid). Researchers say the treatment has shown promise for ...

... findings from a new study researchers say women who are ... might be missing out // on getting screened for the ... might now also need to add colorectal screenings to the ... Centers for Disease Control and Prevention’s 2001 Behavioral Risk Factors ...

... DVT ) is a blood clot that develops deep in ... to the lung. // ,People who require prolonged ... and blood circulation ,especially patients in intensive care and patient ... studies have shown that in critically ill patients , a ...

... Two new studies show high levels of amino acid ... of homocysteine have long been // associated with an ... levels are also known to be associated with homocystinuria, ... in two separate studies, high levels have also been ...

... cycle consisting of periods of growth (anagen), regression ... brief activation of ?-catenin in // telogen-phase adult ... phase. Scientists have discovered that the transient activation ... hair growth. ,Previous work has implicated ...

Other Medicine News:Health News:New Hair in 15 Days Could Now Be A Possibility Say Researchers 2

Controlling Asthma during Pregnancy Hope For Patients With Prostate Cancer Women not Getting Screened Adequately Blood Clots Could Be Very Fatal Blood Tests Can Help Detect Osteoporosis Early In Life New Hair in 15 Days Could Now Be A Possibility Say Researchers

(Date:12/15/2009)... OBP Medical Inc. declares victory in the battle ... hospitals. ,, Doctors at Newton-Wellesley Hospital in Newton, ... Medical,s Under Johnnies(TM) on patients, comfort and satisfaction ... is comparing patients, perception of comfort, privacy and ... Johnnies(TM) against the traditional hospital gown and socks. ...

(Date:12/14/2009)... Dec. 14 Embarrassing and sometimes uncomfortable colonoscopies ... National researchers are taking note of a new screening ... process. The Knoxville-based company, EDP Biotech Corporation ... ColoMarker, an affordable medical device doctors can use to ... "When you consider that 30% of colon cancer ...

(Date:12/14/2009)... 14 The board of directors of Eli ... declared a dividend for the first quarter of 2010 ... ,, The dividend is payable March 10, 2010 ... on ,, February 12, 2010. ,, Lilly, a ... pharmaceutical products by applying the latest research from its ...

[0] Under Johnnies(TM) Proven To Increase Patient Satisfaction by OBP Medical Inc.[0] EDP Biotech Takes Next Step in the Development of ColoMarker [0] Lilly Declares First-Quarter 2010 Dividend

... Vical Incorporated (Nasdaq:,VICL) today reported financial results for ... quarter of 2007 were $3.1 million, compared with,revenues of ... net loss for,the second quarter of 2007 was $8.2 ... of $3.2 million, or $0.11 per share, for the ...

... Progression Rates Are the ... Resources, WALTHAM, Mass., Aug. 7 Decision ... advisory firms focusing on pharmaceutical,and healthcare issues, finds ... Sutent as the clinical gold standard for,the treatment ...

Other Medicine Technology:Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 2 Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 3 Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 4 Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 5 Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 6 Wyeth's Torisel and Roche/Genentech's Avastin Will Challenge Pfizer's Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma 2

Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs Wyeth's Torisel and Roche/Genentech's Avastin Will Challenge Pfizer's Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma

Flat tip, bare fiber, no cooling, polished SMA 905, 3 meters long. Sold in boxes of five. Each part is individually packaged in sterile Tyvek bags....

... unique lateral fiber possessing a ... rotated to any one of ... fibers in one. The fiber ... and coagulation and back to ...

... Ultrafin™ Stirrup is the latest ... stirrup features a roomier boot ... up to an 800 pound ... to position heavy legs more ...

... assist stirrups are designed to travel a full ... They lock tight wherever you release the rotating ... are done at the handle with no need ... socket. The rotation of system was designed to ...

Medicine Products:

Megabeam Non-Contact Fibers for Holmium Lasers QuadraLase™Ultrafin™ Stirrup Lift Assist Stirrup System

Drugs Approved Under Deadline More Likely to Run Into Tro...(and maintaining FDA drug approval he sa...),Health